[Enuresis. Results of a new therapeutic approach].
We present the results of the pharmacological treatment of a syndromic entity particularly common in childhood with a new Oybutinine Chloride drug. We point out that we have achieved positive results in more than 75% from the standpoint of improvement or clinical cure and more than 50% from the urodynamic viewpoint, in the sense of disappearance or improvement of vesical stability. We underline the perfect tolerance of the drug with very few side effects. We conclude that this drug represents a valid alternative in the treatment of this syndrome, although it would be desirable for its effects not to call for such prolonged treatment, which would result in better compliance with the dosages on the part of the patients or heir relatives in the case of small children.
Luque Arana
J I
JI
Perales Cabanas
L
L
D000293:Adolescent; D002648:Child; D004341:Drug Evaluation; D004775:Enuresis / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D008365:Manometry
D008333:Mandelic Acids; C005419:oxybutynin
Enuresis. Resultados de un nuevo enfoque terapéutico.